Senores Pharmaceuticals Limited (NSE:SENORES)
India flag India · Delayed Price · Currency is INR
1,401.60
-3.50 (-0.25%)
Jul 20, 2026, 12:21 PM IST

Senores Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Senores Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of ₹1,174. The average 1-year stock price forecast is 16.22% lower than the current stock price, while the lowest is ₹972.00 (-30.65%) and the highest is ₹1,310 (-6.54%).

Price Target: ₹1,174 (-16.22%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₹972.00₹1,174₹1,208₹1,310
Change-30.65%-16.22%-13.85%-6.54%

Analyst Ratings

The average analyst rating for Senores Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJan '26Feb '26Apr '26May '26Jun '26Jul '26
Strong Buy444444
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total444444

Financial Forecast

Revenue This Year
8.86B
from 6.33B
Increased by 40.00%
Revenue Next Year
11.30B
from 8.86B
Increased by 27.55%
EPS This Year
33.48
from 26.39
Increased by 26.85%
EPS Next Year
45.35
from 33.48
Increased by 35.47%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
141.70M353.37M2.15B3.98B6.33B8.86B
Revenue Growth
-149.38%507.07%85.65%58.85%40.00%
Gross Profit
60.95M225.41M1.06B2.11B3.81B5.49B
Gross Margin
43.01%63.79%49.25%52.94%60.22%62.00%
Operating Income
12.47M108.94M315.80M728.80M1.37B2.15B
Net Income
9.91M84.33M314.50M585.60M1.16B1.54B
EPS
----26.3933.48
EPS Growth
----63.71%26.85%
Forward PE
----25.9441.87
Free Cash Flow
--543.86M-1.04B-2.41B-2.86B-249.00M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High9.5B
Avg8.9B
Low8.5B

Revenue Growth

Revenue Growth202720282029
High
50.4%
Avg
40.0%
Low
35.0%

EPS Forecast

EPS202720282029
High37.30
Avg33.48
Low29.00

EPS Growth

EPS Growth202720282029
High
41.3%
Avg
26.8%
Low
9.9%